Tanvex BioPharma (6541.TW) Q4 2023 Earnings

14MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-2.28
-1.93
-1.58
-1.23

Details

Expected EPS
-1.2261283388978317
Actual EPS
N/A
Surprise EPS
1.23
Surprise Percent
+100%

Description

Tanvex BioPharma (6541.TW) will report earnings of for Q4 2023 on March 14, 2024.

0 Comments

Share your thoughts